« Back to Record
Citation APA

Awada, A., Hendlisz, A., Gil, T., Bleiberg, H., Bartholomeus, S., de Valeriola, D., Dewitte, M., Coppieters, S., Moeller, J., De Becker, D., Meert, A.-P., & Piccart-Gebhart, M. (2001). A clinical, pharmacokinetic and pharmacodynamic phase I study of the raf kinase inhibitor BAY 43-9006 in patients with advanced solid tumors. AACR-NCI-EORTC. Vol. 7 (p. 3768) (October 29 - November 2, 2001: Miami).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/112384

Awada, A., Hendlisz, A., Gil, T., Bleiberg, H., Bartholomeus, S., de Valeriola, D., Dewitte, M., Coppieters, S., Moeller, J., De Becker, D., Meert, A.-P., & Piccart-Gebhart, M. (2001). A clinical, pharmacokinetic and pharmacodynamic phase I study of the raf kinase inhibitor BAY 43-9006 in patients with advanced solid tumors. AACR-NCI-EORTC. Vol. 7 (p. 3768) (October 29 - November 2, 2001: Miami).